Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Haishan Pharmaceutical is a comprehensive pharmaceutical enterprise based in Jinan, Shandong Province, China, that integrates drug research, development, production, and sales. The company primarily focuses on the manufacture of chemical active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, and granules. Its product portfolio spans several major therapeutic areas such as cardiovascular health, anti-infectives, and respiratory medicine. Operating with modern facilities that adhere to Good Manufacturing Practice (GMP) standards, the company serves both the domestic Chinese market and international clients. Shandong Haishan Pharmaceutical is recognized for its commitment to quality control and the production of essential generic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Haishan Pharmaceutical.